These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 23337655)
21. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial. Zhang WJ; Yang XB; Zhong BL J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Tran P; Skolnick P; Czobor P; Huang NY; Bradshaw M; McKinney A; Fava M J Psychiatr Res; 2012 Jan; 46(1):64-71. PubMed ID: 21925682 [TBL] [Abstract][Full Text] [Related]
23. Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder. Endicott J; Lam RW; Hsu MA; Fayyad R; Boucher M; Guico-Pabia CJ J Affect Disord; 2014 Sep; 166():307-14. PubMed ID: 25012446 [TBL] [Abstract][Full Text] [Related]
24. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. Le Noury J; Nardo JM; Healy D; Jureidini J; Raven M; Tufanaru C; Abi-Jaoude E BMJ; 2015 Sep; 351():h4320. PubMed ID: 26376805 [TBL] [Abstract][Full Text] [Related]
25. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder. Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264 [TBL] [Abstract][Full Text] [Related]
26. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder. Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. Wirz-Justice A; Bader A; Frisch U; Stieglitz RD; Alder J; Bitzer J; Hösli I; Jazbec S; Benedetti F; Terman M; Wisner KL; Riecher-Rössler A J Clin Psychiatry; 2011 Jul; 72(7):986-93. PubMed ID: 21535997 [TBL] [Abstract][Full Text] [Related]
29. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder. Jakobsen JC Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628 [TBL] [Abstract][Full Text] [Related]
30. Randomized single-blind multicenter trial comparing the effects of standard and augmented acupuncture protocols on sleep quality and depressive symptoms in patients with depression. Wen X; Wu Q; Liu J; Xu Z; Fan L; Chen X; He Q; Ma R; Wu Y; Jiang S; Xu S; Fu W Psychol Health Med; 2018 Apr; 23(4):375-390. PubMed ID: 28899206 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Lecrubier Y; Clerc G; Didi R; Kieser M Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829 [TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder. Mahableshwarkar AR; Jacobsen PL; Chen Y Curr Med Res Opin; 2013 Mar; 29(3):217-26. PubMed ID: 23252878 [TBL] [Abstract][Full Text] [Related]
33. Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial. Jeon HJ; Fava M; Mischoulon D; Baer L; Clain A; Doorley J; DiPierro M; Cardoos A; Papakostas GI Int Clin Psychopharmacol; 2014 Nov; 29(6):332-8. PubMed ID: 24815673 [TBL] [Abstract][Full Text] [Related]
34. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053 [TBL] [Abstract][Full Text] [Related]
35. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164 [TBL] [Abstract][Full Text] [Related]
37. Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters. Guo T; Xiang YT; Xiao L; Hu CQ; Chiu HF; Ungvari GS; Correll CU; Lai KY; Feng L; Geng Y; Feng Y; Wang G Am J Psychiatry; 2015 Oct; 172(10):1004-13. PubMed ID: 26315978 [TBL] [Abstract][Full Text] [Related]
38. Effects of acupuncture on the symptoms of anxiety and depression caused by premenstrual dysphoric disorder. Carvalho F; Weires K; Ebling M; Padilha Mde S; Ferrão YA; Vercelino R Acupunct Med; 2013 Dec; 31(4):358-63. PubMed ID: 24029029 [TBL] [Abstract][Full Text] [Related]
39. Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials. Harada E; Kato M; Fujikoshi S; Wohlreich MM; Berggren L; Tokuoka H Int J Clin Pract; 2015 Oct; 69(10):1139-48. PubMed ID: 25980552 [TBL] [Abstract][Full Text] [Related]
40. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Kanes S; Colquhoun H; Gunduz-Bruce H; Raines S; Arnold R; Schacterle A; Doherty J; Epperson CN; Deligiannidis KM; Riesenberg R; Hoffmann E; Rubinow D; Jonas J; Paul S; Meltzer-Brody S Lancet; 2017 Jul; 390(10093):480-489. PubMed ID: 28619476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]